酸P450环氧酶衍生的eicosanoids的抗炎性质
1Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, LMRC-322, Boston, MA 02115, USA.
概括
由细胞P450环氧酶生成的环氧乙酸 (EETs) 通过抑制白细胞粘附来减少血管炎症. 这些效应独立于它们的血管扩张性质,突出显示了它们在血管健康中的关键非血管扩张作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 环氧乙酸 (EETs) 是由细胞染色体P450 (CYP) 环氧酶生成的血管活性代谢物.
- EETs模仿内皮衍生的高极化因子,这表明它在调节血管度方面发挥了作用.
- 研究了在人类内皮细胞中负责EET产生的特定CYP异型.
研究的目的:
- 为了确定对人类内皮细胞中EET产生负责的CYP异型.
- 研究EETs在调节内皮细胞粘附分子表达中的作用.
- 阐明EETs影响白细胞粘附于血管壁的机制.
主要方法:
- 人类CYP2J2异型的克隆.
- 用EET治疗内皮细胞或过度表达CYP2J2.
- 评估细胞因子诱导的内皮细胞粘附分子表达.
- 对白细胞粘附于血管壁的分析.
- 研究NF-kappaB和IkappaB激酶信号通路的参与.
主要成果:
- 细胞染色体P450异型CYP2J2被确定为人类内皮细胞中EETs的来源.
- EETs或CYP2J2过度表达的生理度减少了细胞因子诱导的内皮细胞粘附分子表达.
- EETs抑制了白细胞对血管壁的粘附.
- 抑制机制涉及对转录因子NF-kappaB和IkappaB激酶的抑制.
- 这些EET的抗炎作用独立于它们的膜超极化特性.
结论:
- CYP2J2是人类内皮细胞中EETs的重要来源.
- 通过抑制内皮细胞激活和白细胞粘附,EETs具有强大的抗炎作用.
- EETs在调节血管炎症方面发挥着关键的非血管扩张作用,独立于它们的血管扩张作用.
更多相关视频
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...


